<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03329508</url>
  </required_header>
  <id_info>
    <org_study_id>P2B001/003</org_study_id>
    <nct_id>NCT03329508</nct_id>
  </id_info>
  <brief_title>A Phase 3 Study With P2B001 in Subjects With Early Parkinson's</brief_title>
  <official_title>A Phase 3, Twelve-week Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to Its Individual Components in Subjects With Early Parkinson's Disease and to a Calibration Arm of Pramipexole ER.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharma Two B Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharma Two B Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy,
      Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily
      Compared to its Individual Components in Subjects With Early Parkinson's Disease and to a
      Calibration Arm of Pramipexole ER.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 525 eligible subjects with early untreated Parkinson's disease (PD), will be
      randomized to 4 treatment groups. Each subject will participate in the study for
      approximately 18 weeks including a 30 day screening period, 12 week treatment period, and 2
      weeks follow-up period.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>4 arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>double blind study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in total Unified Parkinson's Disease Rating Scale (UPDRS) score (defined as sum of parts II and III, scores (0-160).</measure>
    <time_frame>baseline to week 12</time_frame>
    <description>Superiority of P2B 0.6/0.75 mg as compared to its individual components in the change of total UPDRS score (defined as sum of parts II and III, scores (0-160).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Epworth Sleepiness Scale (ESS) score.</measure>
    <time_frame>baseline to week 12</time_frame>
    <description>Superiority of P2B 0.6/0.75 mg as compared to pramipexole ER in the change of Epworth Sleepiness Scale (ESS) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of Total Parkinson's Disease Questionnaire 39 (PDQ39) score.</measure>
    <time_frame>baseline to week 12</time_frame>
    <description>The efficacy of P2B 0.6/0.75 mg as compared to its individual components in the change of Total PDQ39 score.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">525</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>P2B001</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fixed dose combination once daily capsule of pramipexole and rasagiline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rasagiline capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rasagiline Once daily capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pramipexole capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pramipexole once daily capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pramipexole Extended Release</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pramipexole ER tablet titrated to optimal dose of 1.5, 3.0 or 4.5mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>P2B001</intervention_name>
    <description>Fixed dose once daily combination capsule of pramipexole and rasagiline</description>
    <arm_group_label>P2B001</arm_group_label>
    <other_name>Fixed dose combination of Pramipexole and rasagiline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rasagiline</intervention_name>
    <description>Rasagiline oral capsule</description>
    <arm_group_label>rasagiline capsule</arm_group_label>
    <other_name>rasagiline capsule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pramipexole</intervention_name>
    <description>Pramipexole low dose oral capsule</description>
    <arm_group_label>Pramipexole capsule</arm_group_label>
    <other_name>Pramipexole capsule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pramipexole ER</intervention_name>
    <description>Pramipexole ER titrated to optimal dose</description>
    <arm_group_label>Pramipexole Extended Release</arm_group_label>
    <other_name>Pramipexole Extended Release Oral Tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject has Parkinson's disease consistent with the UK Brain Bank Criteria and must
             have bradykinesia with sequence effect. If rest tremor does not exist must have
             prominent asymmetry of motor function.

          2. Subject with disease duration less than 3 years since diagnosis.

          3. Subject has a H&amp;Y stage score of &lt; 3.

          4. Subject has a MMSE score ≥ 26.

        Exclusion Criteria:

          1. Subject has an atypical parkinsonian syndrome or secondary parkinsonism

          2. Subject has previous exposure to levodopa or a dopamine agonist for longer than 4
             weeks; if previous exposure was less than 4 weeks then it must not be within 2 months
             prior to the baseline visit.

          3. Subject has previous exposure to a MAO-B inhibitor for longer than 4 weeks; if
             previous exposure was less than 4 weeks then it must not be within 3 months prior to
             the baseline visit.

          4. Subject who has taken anticholinergic drugs for PD or amantadine for longer than 4
             weeks; if previous exposure was less than 4 weeks then it must not be within 1 month
             prior to the baseline visit.

          5. Subject has moderate (Child-Pugh categorization B, score 7-9) or severe (Child-Pugh
             categorization C, score 10-15) hepatic impairment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pninit Litman</last_name>
    <role>Study Director</role>
    <affiliation>Pharma2b LTD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avigail Glass</last_name>
    <phone>89472672</phone>
    <email>Avigail@pharma2b.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pninit Litman</last_name>
    <email>pninit@pharma2b.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>P2B001/003 Site Scottsdale</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Ortega Palacios</last_name>
      <email>susan@movementdisorders.us</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Scottsdale</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Anderson</last_name>
      <email>Anderson.Machiko@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site little Rock</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Rassmann</last_name>
      <email>arassmann@uams.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001 site Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Barles</last_name>
      <email>gina.barles@med.usc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001 Study site Englewood,</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janell DeGiorgio</last_name>
      <email>jdegiorgio@kumarneuro.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001 Study Vernon</name>
      <address>
        <city>Vernon</city>
        <state>Connecticut</state>
        <zip>06066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Thurlow</last_name>
      <email>thurlow@uchc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site Boca Raton</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Letty Ginsburg</last_name>
      <email>lginsburg@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Boca Raton</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisbeth Carvajal</last_name>
      <email>lcarvajal@ParkinsonsCenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Smith</last_name>
      <email>lisa.smith@jax.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Cano</last_name>
      <email>c.cano@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Port Charlotte</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33980</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyan Aleshire</last_name>
      <email>Tyan@parkinsonsfl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Sarasota</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Harrell</last_name>
      <email>leighharrell@health.usf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Augusta</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Buff Farrow</last_name>
      <email>bfarrow@augusta.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Honolulu</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Latona Broadwater</last_name>
      <email>latonia.broadwater@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Gill</last_name>
      <email>Molly_E_Gill@rush.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Winfield</name>
      <address>
        <city>Winfield</city>
        <state>Illinois</state>
        <zip>60190</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Hansen</last_name>
      <email>kathy.hansen@nm.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Lyons</last_name>
      <email>kelly.lyons@att.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Wagner</last_name>
      <email>renee.wagner@uky.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond James</last_name>
      <email>rcjames@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site East Lansing</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doozie Russell</last_name>
      <email>doozie.russell@ht.msu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site west Bloomfield</name>
      <address>
        <city>West Bloomfield</city>
        <state>Michigan</state>
        <zip>48322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pat Kaminsky</last_name>
      <email>pkamins1@hfhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Golden Valley</name>
      <address>
        <city>Golden Valley</city>
        <state>Minnesota</state>
        <zip>55427</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Niesen</last_name>
      <email>sherry.niesen@parknicollet.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ammel</last_name>
      <email>ammelm@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site New Hampshire</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Jeffreys</last_name>
      <email>Charlotte.A.Jeffreys@hitchcock.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Camden</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>P2B001 Study site Edison</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>08820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Briana DeCarvalho</last_name>
      <email>Briana.DeCarvalho@hackensackmeridian.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Albuquerque</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JoAnn Harnar</last_name>
      <email>Joann.Harnar@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Brooklyn</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofya Glazman</last_name>
      <email>sofya.glazman@downstate.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Commack</name>
      <address>
        <city>Commack</city>
        <state>New York</state>
        <zip>11725</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Gardella</last_name>
      <email>researchli@parkinsonscenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Bratton</last_name>
      <email>Joan.bratton@mssm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001 Study site Syracuse</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Pusey</last_name>
      <email>PuseyJ@upstate.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Williamsville</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Shepherd</last_name>
      <email>rlaporta@buffalo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Asheville</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Woodard</last_name>
      <email>research@ashneuro.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001 study site Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Neefus</last_name>
      <email>erin.neefus@uc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Toledo</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Wilson</last_name>
      <email>stephanie.wilson@utoledo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Hershey</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samyuktha Ravi</last_name>
      <email>sravi1@pennstatehealth.psu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Greenville</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>p2B001/003 Study site Memphis</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Nashville</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>P2B001/003 site Bedford</name>
      <address>
        <city>Bedford</city>
        <state>Texas</state>
        <zip>76021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giselle Huet</last_name>
      <email>Giselle.Huet@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Alexandria</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karlie Smith</last_name>
      <email>karlie.smith@inova.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karlie Smith</last_name>
      <email>karlie.smith@inova.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Richmond</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Site Kirkland</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Fierro</last_name>
      <email>EvergreenResearch@EvergreenHealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuhira Himed</last_name>
      <email>himed@hhsc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Puja Bhakta</last_name>
      <email>Puja.Bhakta@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden-wuerttemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothea Hueske</last_name>
      <email>dorothea.hueske@uni-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Württemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerit Kammel</last_name>
      <email>gerit.kammel@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Haag</name>
      <address>
        <city>Haag</city>
        <state>Bayern</state>
        <zip>83527</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Deuschl</last_name>
      <email>anja.deuschl@kliniken-muehldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Haag</name>
      <address>
        <city>Haag</city>
        <state>Bayern</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Deuschl</last_name>
      <email>anja.deuschl@kliniken-muehldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site München</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Luesebrink</last_name>
      <email>antje.luesebrink@tum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Hanau</name>
      <address>
        <city>Hanau</city>
        <state>Hessen</state>
        <zip>63450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rommi Born</last_name>
      <email>rommi_born@klinikum-hanau.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Bochum</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-westfalen</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lennard Herrmann</last_name>
      <email>lennard.herrmann@rub.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Münster</name>
      <address>
        <city>Münster</city>
        <state>Nordrhein-westfalen</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Lena Schwake</last_name>
      <email>Anna-lena.Schwake@ukmuenster.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Dresden</name>
      <address>
        <city>Dresden</city>
        <state>SaACHSEN</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Sauer</last_name>
      <email>angela.sauer@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Kalb</last_name>
      <email>andrea.kalb@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Gera Germany</name>
      <address>
        <city>Gera</city>
        <state>Thuringen</state>
        <zip>07551</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Oehlwein</last_name>
      <email>anna.haraszti@online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Gera</name>
      <address>
        <city>Gera</city>
        <state>Thuringen</state>
        <zip>07551</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>praxis-oehlwein@online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ehret Reinhard</last_name>
      <email>termine@neurologie-berlin.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>fabian.klostermann@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Sant Cugat del Vallés</name>
      <address>
        <city>Sant Cugat del Vallés</city>
        <state>Barcelona</state>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Aguilar</last_name>
      <email>carlos.aguilar@quironsalud.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Mostoles</name>
      <address>
        <city>Mostoles</city>
        <state>Madridid</state>
        <zip>28938</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Desiree Gonzalez</last_name>
      <email>dgonzalez@hmhospitales.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Pamplona</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nieves Diez Gandia</last_name>
      <email>ndiezg@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site La Paz</name>
      <address>
        <city>Madrid</city>
        <state>S</state>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yolanda Herrero</last_name>
      <email>yherrero89@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>jkulisevsky@hsp.santpau.es</email>
    </contact>
    <contact_backup>
      <last_name>Antonia Campolongo</last_name>
      <email>ACampolongo@santpau.cat</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Santa Cruz and San Pablo</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonia Campolongo</last_name>
      <email>acampolongo@santpau.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Vall d'Hebrón</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Aguilar</last_name>
      <email>carla.aguilar@vhir.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Navarra</name>
      <address>
        <city>Madrid</city>
        <zip>28027</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Martin Bastida</last_name>
      <email>amartin@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 study site Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Pareés</last_name>
      <email>isabel.parees@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Ruiz-Lopez</last_name>
      <email>martaruiznrl@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B0011/003 Study site HM Centro Integral de Neurociencias (CINAC)</name>
      <address>
        <city>Madrid</city>
        <zip>28938</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariana Hernandez-Gonzalez-Monje</last_name>
      <email>mariana.hgmonje@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Puerta de Hierro - Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabela Novo Ponte</last_name>
      <email>snovoponte@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>P2B001/003 Study site Policlinica Gipuzkoa</name>
      <address>
        <city>San Sebastian</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>Nadegevanblercom@Yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>October 30, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>March 8, 2020</last_update_submitted>
  <last_update_submitted_qc>March 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pramipexole</mesh_term>
    <mesh_term>Rasagiline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

